November, 2021

article thumbnail

FDA clears GE Healthcare AI algorithm for patient intubation

pharmaphorum

An artificial intelligence algorithm developed by GE Healthcare that helps with the placement of endotracheal tubes (ETTs) has been approved by the FDA. The new tool – part of GE’s Critical Care Suite 2.0 – helps bedside staff and radiologists assess patients before intubation – for example prior to ventilation in patients with critical COVID-19 – and make sure their ETTs are positioned correctly.

FDA 145
article thumbnail

Nearly 32,000 Kaiser Permanente workers set to strike Nov. 15. Tens of thousands more mulling their own demonstrations

Fierce Healthcare

Nearly 32,000 Kaiser Permanente workers set to strike Nov. 15. Tens of thousands more mulling their own demonstrations. dmuoio. Fri, 11/05/2021 - 10:58.

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Gene-edited cell replacement therapy for diabetes set to enter the clinic

Outsourcing Pharma

CRISPR Therapeutics and ViaCyte, Inc. have received the green light from Health Canada for their Clinical Trial Application for VCTX210: an allogeneic, gene-edited, immune-evasive, stem cell-derived therapy for the treatment of type 1 diabetes (T1D).

article thumbnail

University of Glasgow reveals drug design for new Alzheimer’s treatments

Pharma Times

A team of scientists and pharmaceutical collaborators have discovered a ‘bench to bedside’ drug design, which will hopefully improve the future treatment of Alzheimer’s disease.

67
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Native Advertising is Exploding Across Healthcare, Have you Jumped In?

Pharma Marketing Network

In the last 2 years, and accelerated by Covid, native advertising has exploded across healthcare for DTC and HCP marketing. Native ads have been adopted by all healthcare industries including pharma, device, health systems, retailers, pharmacies, payers, and the gamut of regional service providers. But there are still a handful of advertiser holdouts, and they are missing out on highly engaged audiences.

105
105
article thumbnail

Trial of Jazz’ cannabis drug in glioblastoma will start next year

pharmaphorum

An investigator-led trial of Jazz Pharma’s cannabis extract-based drug Sativex in glioblastoma – an aggressive form of brain cancer – will get underway in the UK next year. The three-year phase 2 trial will be carried out by researchers at Leeds University led by professor of clinical oncology and neuro-oncology Susan Short, and see if adding Sativex (nabiximols) to standard chemotherapy for recurrent glioblastoma can extend survival.

More Trending

article thumbnail

Boost for Amazon’s telehealth business, as Hilton signs up

pharmaphorum

Amazon’s push into the provision of remote healthcare services has been rewarded with a top-tier corporate client – the Hilton hotel chain. The deal – first reported by Reuters – involves the Amazon Care platform, which includes remote, online consultations with clinicians, as well as home visits in some areas. It provides primary and preventive care, ongoing support for chronic conditions, and referrals to secondary and tertiary care.

Hospitals 133
article thumbnail

Digital therapeutic cuts opioid use disorder care costs, says study

pharmaphorum

A real-world study of digital therapeutic (DTx) for opioid use disorder has found that patient show used it had 46% fewer hospital stays than a control group, saving more than $2,700 over a nine-month period. The study of Pear Therapeutics’ reSET-O found that the total cost of hospital and clinician costs were $11,141 among 64 patients who were prescribed the DTx but didn’t use it, but fell to $8,733 among active users of the 12-week course.

Hospitals 132
article thumbnail

AZ, Moderna say mRNA drug is promising in heart failure

pharmaphorum

Moderna is already riding high on the strength of its mRNA-based COVID-19 vaccine, but the broader potential of its technology has been shown in a new AstraZeneca-partnered candidate for heart failure. At the American Heart Association (AHA) congress, the two partners presented results from the phase 2a EPICCURE trial that showed that injecting their AZD8601 candidate directly into the heart muscle of patients undergoing coronary artery bypass graft (CABG) surgery seemed to improve heart functio

Vaccines 130
article thumbnail

Respira Labs’ wearable device listens for lung diseases

pharmaphorum

US company Respira Labs has developed a device worn on the chest that uses tiny speakers and microphones to project sound into the lungs and listen for signals that could indicate serious lung diseases. The Sylvee wearable uses an artificial intelligence (AI) algorithm to interpret sounds that may indicate trapped air in the lungs, which can be a sign of ill health, using acoustic resonance – similar to the way an ultrasound machine creates visual images.

Hospitals 122
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Notable nabs $100M to automate administrative tasks in healthcare, boosts valuation to $600M

Fierce Healthcare

Notable nabs $100M to automate administrative tasks in healthcare, boosts valuation to $600M. rtorrence. Wed, 11/03/2021 - 11:07.

145
145
article thumbnail

Epic's sepsis algorithm may have caused alert fatigue with 43% alert increase during pandemic

Fierce Healthcare

Epic's sepsis algorithm may have caused alert fatigue with 43% alert increase during pandemic. rtorrence. Tue, 11/23/2021 - 12:45.

141
141
article thumbnail

Former Livongo exec launches women's health startup that uses data for personalized care

Fierce Healthcare

Former Livongo exec launches women's health startup that uses data for personalized care. hlandi. Wed, 11/03/2021 - 11:24.

145
145
article thumbnail

10 rural states launch lawsuit against CMS' COVID-19 vaccine mandate for healthcare workers

Fierce Healthcare

10 rural states launch lawsuit against CMS' COVID-19 vaccine mandate for healthcare workers. dmuoio. Thu, 11/11/2021 - 12:57.

Vaccines 142
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

New COVID variant ‘may sidestep vaccine protection’

pharmaphorum

A new variant of COVID-19 identified in Botswana with dozens of mutations is being watched closely, amid fears it could be resistant to the effect of currently-used vaccines. The B.1.1.529 variant has more mutations affecting the spike protein targeted by vaccines than any other strain identified to date, although it’s not yet clear if it is more or less transmissible.

Vaccines 116
article thumbnail

Time for change: PhRMA survey shows insurance creates barriers to healthcare in US

pharmaphorum

Health insurance is not enough to provide the necessary affordable access to care for the US’ most vulnerable, finds new PhRMA report. For too many Americans, insurance coverage is not providing the health security it’s meant to. The Pharmaceutical Research and Manufacturers of America’s (PhRMA) first Patient Experience Survey (PES) has found that three in ten people with medical insurance still face financial barriers to accessing healthcare and prescription medicines.

Insurance 116
article thumbnail

UK-wide whole genome sequencing for newborns is feasible – but there are some key questions to answer first

pharmaphorum

Genomics England, the Department of Health and Social Care’s genome-sequencing hub, has this year announced that support for whole genome sequencing (WGS) has reached a level at which its national rollout on the NHS may someday become a reality. The timing of this announcement is particularly opportune, as increasing knowledge and advances in WGS amongst scientists has resulted in the technology becoming increasingly affordable and effective, making its incorporation into the existing standardis

Hospitals 116
article thumbnail

Re-envisioning mental health treatment using clinical VR

pharmaphorum

Skip Rizzo, PhD, research director for medical virtual reality at the University of Southern California’s Institute for Creative Technologies (USC ICT), tells us how its virtual reality (VR) therapy BRAVEMIND is changing PTSD treatment and how pharma can leverage clinical VR. “There’s a strong evidence base for VR applications in many areas, but it’s also breaking down barriers to care.

article thumbnail

Pfizer’s pill cuts COVID deaths and hospitalisations by 90%

pharmaphorum

An oral antiviral drug developed by Pfizer has been shown to dramatically cut the risk of hospitalisation or death from COVID-19 when given in the early stages of infection. The phase 3 trial found that Paxlovid – which combines new protease inhibitor PF-07321332 with already-approved HIV drug ritonavir – reduced the risk of hospitalisation or death by 89% when given to newly-diagnosed adults who were at risk of developing severe COVID-19 in the EPIC-HR trial.

Hospitals 116
article thumbnail

Parliamentary probe finds racism evidence in NHS sickle cell care

pharmaphorum

Patients with sickle cell disease are facing racism in the NHS that is putting their lives a risk, claims a new report. . The All-Party Parliamentary Group (APPG) document – entitled No One’s Listening and partnered with the Sickle Cell Society – found “serious care failings” in acute services and evidence of attitudes underpinned by racism in the care of people with SCD, a red blood cell disorder that mainly affects black people.

article thumbnail

Novartis’ ‘wild card’ drug Scemblix gets FDA nod for leukaemia

pharmaphorum

Novartis has claimed FDA approval for one of its ‘wild card’ drugs – Scemblix – a first-in-class STAMP inhibitor for patients with previously-treated chronic myeloid leukaemia (CML). Scemblix (asciminib) was one of a clutch of high risk, high reward drug candidates for a range of diseases that Novartis chief executive Vas Narasimhan said last year were flying under-the-radar of industry watchers, but could potentially develop into blockbusters.

FDA 115
article thumbnail

Part B premiums set to rise in 2022 as Medicare braces for potential high-cost therapies like Aduhelm

Fierce Healthcare

Part B premiums set to rise in 2022 as Medicare braces for potential high-cost therapies like Aduhelm. pminemyer. Fri, 11/12/2021 - 18:06.

132
132
article thumbnail

Industry Voices—Why primary care is the future of sustainable healthcare in the U.S.

Fierce Healthcare

Industry Voices—Why primary care is the future of sustainable healthcare in the U.S. hlandi. Sat, 11/06/2021 - 21:45.

141
141
article thumbnail

Federal judge halts CMS' COVID-19 vaccine mandate for healthcare workers in 10 rural states

Fierce Healthcare

Federal judge halts CMS' COVID-19 vaccine mandate for healthcare workers in 10 rural states. dmuoio. Mon, 11/29/2021 - 15:30.

Vaccines 137
article thumbnail

How this telehealth startup aims to address mental illness with ketamine therapy

Fierce Healthcare

How this telehealth startup aims to address mental illness with ketamine therapy. agliadkovskaya. Mon, 11/08/2021 - 13:17.

138
138
article thumbnail

Medicare startup EasyHealth gets $135M in series A to fill information gaps

Fierce Healthcare

Medicare startup EasyHealth gets $135M in series A to fill information gaps. rtorrence. Fri, 11/19/2021 - 10:10.

143
143
article thumbnail

Biden admin finalizes rule that requires insurers to submit data on drug costs, rebates

Fierce Healthcare

Biden admin finalizes rule that requires insurers to submit data on drug costs, rebates. pminemyer. Wed, 11/17/2021 - 16:42.

Insurance 136
article thumbnail

Here are the policies and reforms that could reshape healthcare in the $2T bill just passed by the House

Fierce Healthcare

Here are the policies and reforms that could reshape healthcare in the $2T bill just passed by the House. rking. Fri, 11/19/2021 - 10:09.

130
130
article thumbnail

Report ranks 10 most cost-efficient hospitals in the U.S., identifies $8B in potential Medicare savings

Fierce Healthcare

Report ranks 10 most cost-efficient hospitals in the U.S., identifies $8B in potential Medicare savings. agliadkovskaya. Mon, 11/08/2021 - 18:03.

Hospitals 126
article thumbnail

MedArrive nabs $25M to ramp up at-home health services, expand into new states

Fierce Healthcare

MedArrive nabs $25M to ramp up at-home health services, expand into new states. hlandi. Fri, 11/19/2021 - 16:56.

141
141
article thumbnail

AZ eyes FDA verdict on Lynparza in adjuvant breast cancer in Q1

pharmaphorum

The FDA will deliver a verdict on AstraZeneca’s PARP inhibitor Lynparza as an adjuvant treatment for breast cancer in the first quarter of next year, after granting the application a priority review. AZ and partner Merck & Co have filed Lynparza (olaparib) for use in BRCA-mutated, HER2-negative early breast cancer in patients who have already been treated with chemotherapy either before or after surgery and are at high risk of the disease coming back.

FDA 111
article thumbnail

UK sets aside £248m to “digitise” NHS diagnostics

pharmaphorum

The UK government has announced £248 million in spending over the next year for a project to make it easier for patient test results and scans to be shared between hospitals, labs and GP surgeries. The aim is to “digitise diagnostics care” across the NHS, reducing the time it takes to diagnose health problems and get treatment started earlier, helping to address the massive backlog in care caused by the pandemic, according to a Department of Health and Social Care (DHSC) statement.

Hospitals 111
article thumbnail

Experts weigh in on ways to combat growing antibiotic resistance amid COVID-19

Fierce Healthcare

Experts weigh in on ways to combat growing antibiotic resistance amid COVID-19. agliadkovskaya. Thu, 11/18/2021 - 15:20.

136
136
article thumbnail

Mix-and-match COVID-19 vaccines: New trial to add to growing body of research

Outsourcing Pharma

A new clinical trial of heterologous â or âmix-and-matchâ â combinations of COVID-19 vaccines is set to start in Pakistan: seeking to add to research on the effectiveness of such combinations.

Vaccines 111